Safety of BK1301 in healthy adults

Phase 2

• Conditions: Diphtheria, Tetanus, Pertussis prevention

• Registration Number: JPRN-jRCT2080222663
• Lead Sponsor: The Research Foundation for Microbial Diseases of Osaka University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-11-21
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Healthy adults

Exclusion Criteria

History of diphtheria, tetanus, pertussis injection
Individuals who received vaccines containing diphtheria, tetanus, or pertussis within 5 years

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
safety

Secondary Outcome Measures

Name	Time	Method
immunogenicity